NCT04092036

Brief Summary

The aim of the study to examine Optic Nerve Sheath Diameter measurement for prediction of fluid responsiveness in hemodynamically unstable patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
28 days until next milestone

Study Start

First participant enrolled

October 15, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2020

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

5 months

First QC Date

September 13, 2019

Last Update Submit

September 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • The cut-off value of optic nerve sheath diameter (ONSD) for prediction of fluid responsiveness

    first day

Secondary Outcomes (1)

  • Correlation between Stroke Volume Variation (by electrical cardiometry) and ONSD

    first day

Study Arms (1)

Unstable patients

Patients on mechanical ventilation, 18 years or older and developing hypotension (Mean arterial blood pressure) \<65 mmHg

Device: Optic Nerve Sheath Diameter (ONSD) measurement by ultrasound

Interventions

ONSD measurements will be performed in the supine patient. Ultrasound gel will be applied over the closed upper eyelid. The ultrasound probe will be placed on the temporal area of the eyelid. Then the probe will be angled in order to display the entry of the optic nerve into the globe. ONSD will be measured 3 mm behind the globe in the transverse plane perpendicular to the optic nerve. For each optic nerve three measurements will be made. The ONSD corresponds to the mean of the six values which will be obtained from each patient (three measurements for each eye).

Unstable patients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Tanta University Hospitals at the surgical intensive care unit

You may qualify if:

  • Patients on mechanical ventilation
  • years or older
  • patients developing hypotension (Mean arterial blood pressure) \<65 mmHg

You may not qualify if:

  • Patients with Spontaneously breathing activity.
  • Patients with a history of intracranial disease e.g. (stroke, TBI, causes of increased intracranial pressure).
  • local cause in the eye as (Glaucoma, Single eye)
  • Need for high PEEP.
  • Known history of cardiac disease.
  • Organ/s failure at admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Hadeel Ibraheim Elsagheir, MBBCH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at Anesthesiology, Surgical ICU and Pain Medicine Department

Study Record Dates

First Submitted

September 13, 2019

First Posted

September 17, 2019

Study Start

October 15, 2019

Primary Completion

March 14, 2020

Study Completion

March 14, 2020

Last Updated

September 17, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will share